These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Letter: G.A.B.A. and Huntington's chorea. Barbeau A Lancet; 1973 Dec; 2(7844):1499-500. PubMed ID: 4129342 [No Abstract] [Full Text] [Related]
27. Dopamine receptors in the basal ganglia: relevance to Parkinson's disease. Strange PG Mov Disord; 1993 Jul; 8(3):263-70. PubMed ID: 8101967 [TBL] [Abstract][Full Text] [Related]
28. Images in neuroscience. Neuroimaging, XII. SPECT imaging of dopamine nerve terminals. Seibyl JP; Marek K; Innis RB Am J Psychiatry; 1996 Sep; 153(9):1131. PubMed ID: 8780413 [No Abstract] [Full Text] [Related]
29. The pharmacology of tardive dyskinesias. Klawans HL Am J Psychiatry; 1973 Jan; 130(1):82-6. PubMed ID: 4264755 [No Abstract] [Full Text] [Related]
30. Dopamine receptors, motor responses, and dopaminergic agonists. Luquin-Piudo MR; Sanz P Neurologist; 2011 Nov; 17(6 Suppl 1):S2-8. PubMed ID: 22045321 [TBL] [Abstract][Full Text] [Related]
31. Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease. Booij J; Bergmans P; Winogrodzka A; Speelman JD; Wolters EC Synapse; 2001 Feb; 39(2):101-8. PubMed ID: 11180497 [TBL] [Abstract][Full Text] [Related]
32. Hard target: understanding dopaminergic neurotransmission. Nestler EJ Cell; 1994 Dec; 79(6):923-6. PubMed ID: 8001139 [No Abstract] [Full Text] [Related]
33. Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons. Hara M; Fukui R; Hieda E; Kuroiwa M; Bateup HS; Kano T; Greengard P; Nishi A J Neurochem; 2010 May; 113(4):1046-59. PubMed ID: 20236221 [TBL] [Abstract][Full Text] [Related]
34. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. Hornykiewicz O Adv Neurol; 1993; 60():140-7. PubMed ID: 8420131 [No Abstract] [Full Text] [Related]
35. Parkinsonism: candidate disorder for implanted pumps? Nutt JG Ann N Y Acad Sci; 1988; 531():194-9. PubMed ID: 2898229 [No Abstract] [Full Text] [Related]
37. Huntington chorea is not associated with hyperactivity of nigrostriatal dopaminergic neurons: studies in postmortem tissues and in rats with kainic acid lesions. Melamed E; Hefti F; Bird ED Neurology; 1982 Jun; 32(6):640-4. PubMed ID: 6211637 [TBL] [Abstract][Full Text] [Related]
38. Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease. Elsworth JD; Roth RH Exp Neurol; 1997 Mar; 144(1):4-9. PubMed ID: 9126143 [TBL] [Abstract][Full Text] [Related]